HomeAdvocacy Advocacy News

Advocacy News

Displaying results 1-10 (of 181)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >| 

Express Scripts Announces New Formulary Design Option

This week, Express Scripts announced that it would provide clients with the ability to opt for its new National Preferred Flex Formulary Design. As opposed to favoring drugs that garner the most rebate dollars, the new benefit design intends to favor drugs that have lower list prices to begin with.

READ MORE

CSRO Hosts State Society Leaders at the ACR

On Monday, October 22nd, CSRO hosted a breakfast for state rheumatology society leaders present at the ACR. Attendees had the opportunity to learn more about emergent patient access issues, CSRO’s plans for 2019, and hear from a speaker who discussed implementation and compliance issues with existing patient access laws.

READ MORE

CSRO Discusses New Drug Payment Model with Key Agency Officials

Last week, CSRO’s Past President and National Advocacy Chair, Michael Schweitz, MD, participated in one-on-one discussions with Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma and Special Advisor to the Administrator Jeet Guram, MD, to discuss details about the Trump Administration’s potential International Pricing Index Model for Medicare Part B Drugs.

READ MORE

New Data Emerges on Co-Pay Accumulator Programs

The CSRO has been deeply concerned about the expanded implementation of a new utilization management tool known as co-pay accumulator programs over the course of 2018.

READ MORE

Annual State Society Advocacy Conference a Success

The CSRO was excited to host many members of the state rheumatology societies and other partners in Chicago on Saturday, September 15th for the annual State Society Advocacy Conference (SSAC).

READ MORE

CSRO Policy Update, August 2018, Issue 7

As the last of the 2018 regular sessions wind down across the states, CSRO is happy to report that the year to date has been marked by a number of successes on the patient access front. As

READ MORE

Illinois Enacts Non-medical Switching Protections

On Friday, August 24th, Illinois’ Governor signed HB4146 into law, providing patients much needed protections from non-medical switching.

READ MORE

CSRO Discusses Part B and D with CMS

Members of CSRO’s executive board recently met with CMS to discuss Part B and D drug pricing. Doctors Michael Schweitz, Madelaine Feldman, Greg Schimizzi traveled to D.C. to present CSRO’s feedback on recent proposals and provide rheumatology’s perspective on the programs.

READ MORE

CSRO attends National Conference of State Legislatures

Each year state legislators from across the country congregate to discuss innovative solutions that can be implemented to solve problems faced in common by various state legislatures.

READ MORE

2018 Session Capped with Approval of Three States’ Biosimilar Measures

Over the course of the past year, interchangeable biosimilar substitution laws with physician communication provisions have continued to find enormous success in the states.

READ MORE

Displaying results 1-10 (of 181)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|